Max Neeman International has expanded its presence in the Asia-Pacific region with new locations and capabilities in Bangladesh, Sri Lanka and Malaysia. Max Neeman also has locations in India, Europe, and North America.
 
In Bangladesh, the company has contacts with the leading investigators and physicians, and is capable of running projects end to end. The company’s in-house regulatory team handles all regulatory submissions and ethics committee submissions to Bangladesh Medical Research Council (BMRC). Also, Max Neeman CRAs and PMs will manage site selection, qualification, and monitoring of all sites per ICH GCP and local regulatory guidelines.
 
In Sri Lanka and Malaysia, project management for the studies is carried out by Max Neeman’s operations team for site qualification and monitoring of sites to ensure ICH GCP and local regulatory guidelines.
 
“Max Neeman’s additional Asia-Pac presence allows us an access to these geographies and hence the subjects. All countries have Regulatory requirements; India is no different and while it may take some additional time to approval, Max Neeman will be ready to start and Sponsors can rest assure that faster recruitment will make up the time,” said chief operating officer, Dr. Renu Razdan.